Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
08/2004
08/05/2004US20040152690 Analgesics; neuropathic pain; antiinflamamtory agents; oral diseases; headaches; antiarthritic agents; vision disorders; skin disorders; inflammatory bowel disorders; benzimidazole compounds
08/05/2004CA2513349A1 Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1
08/05/2004CA2512899A1 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
08/05/2004CA2511491A1 Androgen receptor antagonists
08/05/2004CA2511089A1 Androgen receptor antagonists
08/05/2004CA2509764A1 Diazepanes derivatives useful as lfa inhibitors
08/05/2004CA2509456A1 Substituted alkyl amido piperidines
08/04/2004EP1443046A1 Novel 4-(2furoyl)aminopiperidines, intermediates in synthesizing the same, process for producing the same and medicinal use of the same
08/04/2004EP1442041A1 Azabicyclic-substituted-heteroaryl compounds for the treatment of disease
08/04/2004EP1442034A1 Benzimidazole derivatives and their use as kdr protein kinase inhibitors
08/04/2004EP1442025A1 Pyrimidinones as melanin concentrating hormone receptor 1
08/04/2004EP1442019A1 Amide derivatives as glycogen synthase kinase 3-beta inhibitors
08/04/2004EP1441734A1 Dihydroxypyrimidine carboxamide inhibitors of hiv integrase
08/04/2004EP1441733A1 Pharmaceutical compositions for the treatment of leukemia comprising dioxolane nucleosides analogs
08/04/2004EP1441729A1 Piperazine bis-amide derivatives and their use as antagonists of the orexin receptor
08/04/2004EP1441728A2 Modulators of the cholesterol biosynthetic pathway
08/04/2004EP1441725A1 Benzimidazoles and analogues and their use as protein kinases inhibitors
08/04/2004EP1441724A1 Methods of increasing endogenous testosterone levels
08/04/2004EP1441721A2 Use of endothelin receptor antagonists in the treatment of tumour diseases
08/04/2004EP1441718A2 Carbinols for the treatment of neuropathic dysfunction
08/04/2004EP1441683A2 Trisubstituted triazine compounds, and methods for making an using the compounds, which have antitubulin activity
08/04/2004EP1140903B1 Aromatic amides
08/04/2004EP1091956B1 Muscarinic antagonists
08/04/2004EP0984944B1 Substituted 4-(3-alkenyl-benzoyl)-pyrazoles
08/04/2004CN1518546A Selective anthranilamide pyridine amides as inhibitors of VEGRF-2 and VEGFR-3
08/04/2004CN1518545A Novel, ascorbic acid compounds, methods of synthesis and application use thereof
08/04/2004CN1518543A Pyrazole derivatives and their use as protein kinase inhibitors
08/04/2004CN1518542A Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
08/04/2004CN1518534A Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
08/04/2004CN1518447A Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents
08/04/2004CN1160350C Method for preparing asymmetric lactone
08/04/2004CN1160344C Compounds for treatment of asthma, allergy and inflammatory disorders and its use
08/04/2004CN1160341C Substituted 2,4-diamino-1,3,5-triazines
08/04/2004CN1160332C N-aryloxyethylamine derivatives for treatment of depression
08/03/2004US6770766 Polyamino acid-catalyzed process for the enantioselective epoixdation of α,β-unsaturated enones and α,β-unsaturated sulfones
08/03/2004US6770668 Pharmaceutically active compounds and methods of use
08/03/2004US6770666 Fused-ring compounds and use thereof as drugs
08/03/2004US6770653 Method and dosage form for treating tumors by the administration of tegafur, uracil, folinic acid, paclitaxel and carboplatin
08/03/2004US6770627 Piperizine-4-phenyl derivatives as inhibitors of the interaction between mdm2 and p 53
08/03/2004US6770595 Cyclic imines as pesticides
08/03/2004US6770259 Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation
08/03/2004CA2294716C Method for drying anhydrous paroxetine hydrochloride
08/03/2004CA2270386C Process for substituted pyridines
08/03/2004CA2058768C Treatment and control of ocular development
07/2004
07/29/2004WO2004063193A1 4-{`3-(sulfonylamino) phenyl! `1-(cyclymethyl) piperidin-4-ylidene! methyl} benazmide derivatives as delta opioid receptor ligands for the treatment of pain, anxiety and functional gastrointestinal disorder
07/29/2004WO2004063192A1 Imidazolyl pyrimidine derivatives useful as il-8 receptor modulators
07/29/2004WO2004063191A1 Pyridine derivatives useful for inhibiting sodium/calcium exchange system
07/29/2004WO2004063188A1 Paharmaceutical process and compounds prepared thereby
07/29/2004WO2004063187A1 Substituted benzoyl derivatives uses as herbicides
07/29/2004WO2004063171A1 N- (1-benzyl-2-oxo-2- (1-piperazinyl) ethyl) -1-piperidincarboxamid-derivatives and related compounds use as cgrp-antagonists for treating a headache
07/29/2004WO2004063169A1 Hydroxamid acid derivatives as histone deacetylase (hdac) inhibitors
07/29/2004WO2004063163A1 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
07/29/2004WO2004063161A1 Saturated and unsaturated heteroarylcycloalkylmethyl amines as anti-depressants
07/29/2004WO2004063157A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
07/29/2004WO2004063156A1 Novel indole derivates as fabp-4 inhibitors
07/29/2004WO2004063152A2 Lansoprazole formulations and related processes and methods
07/29/2004WO2004062663A1 Use of substituted 2-phenylbenzimidazoles as medicaments
07/29/2004WO2004062662A1 Aminoindazole derivatives and use thereof as kinase inhibitors
07/29/2004WO2004062609A2 Pyrimidine derivatives as il-8 receptor antagonists
07/29/2004WO2004062562A2 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
07/29/2004WO2004050024A3 3-aminopyrrolidine derivatives as modulators of chemokine receptors
07/29/2004WO2004045533A3 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
07/29/2004WO2004033422A3 Modulation of anxiety through blockade of anandamide hydrolysis
07/29/2004WO2004031401A3 Novel tyrosine kinases inhibitors
07/29/2004WO2004018419B1 Benzimidazole quinolinones and uses thereof
07/29/2004WO2004014868A8 Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors
07/29/2004WO2003040107A8 Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity
07/29/2004US20040147754 Novel process
07/29/2004US20040147752 Carbazole derivatives for the treatment of NPY related diseases
07/29/2004US20040147748 Increasing insulin secretion; type II diabetes; such as 2-(3-Chloro-4-methanesulfonyl-phenyl)-3-cyclopentyl-N-(5-methylsulfanyl-pyrazin-2-yl)-propionamide
07/29/2004US20040147745 Novel compounds and compositions as protease inhibitors
07/29/2004US20040147728 Method for increasing hydrophilicity of fluorescent label compounds
07/29/2004US20040147596 Antidiabetic agents; immunology diseases; antiinflammatory agents
07/29/2004US20040147593 Eating disorders; sleep disorders; obesity
07/29/2004US20040147584 1,3-diarylprop-2-en-1-ones, compositions containing them and use thereof
07/29/2004US20040147580 Therapy for bacteria infections
07/29/2004US20040147576 Cardiovascular disorders; thrombosis; anticoagulants
07/29/2004US20040147573 Metalloproteinase inhibitors
07/29/2004US20040147569 Cell differentiation inducer
07/29/2004US20040147559 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
07/29/2004US20040147556 Analgesics; anxiolytuic agents; gastrointestinal disorders
07/29/2004US20040147553 Efficiency; side effect reduction; antiarthriutic agents; autoimmune diseases
07/29/2004US20040147528 Crystal structure; antidepressants; anxiolytic agents; eating disorders; bipolar disorders; Alzheimer's disease; sleep disorders;
07/29/2004US20040147520 Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists
07/29/2004US20040147519 Sulfonylquinoxalone acetamide derivatives as bradykinin antagonists
07/29/2004US20040147512 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
07/29/2004US20040147507 Compositions useful as inhibitors of JAK and other protein kinases
07/29/2004US20040147502 Beta lactam compounds and their use as inhibitors of tryptase
07/29/2004US20040147497 N-formyl derivatives of paroxetine
07/29/2004US20040147479 suitable for large-scale production with reduced cost and environmental impact; chemical intermediates
07/29/2004US20040147429 Endogenous, constitutively activated G protein-coupled orphan receptors
07/29/2004US20040147035 Diaminorhodamine derivative
07/29/2004US20040146542 Non-therapeutical process for deterring vermin from warm-blooded animals, whereby 2-substituted-piperidine compound is is applied topically, together with a spreading additive, to the skin, the pelt or the plumage of the warm-blooded animal
07/29/2004US20040146438 Method for recovery of metals from metal-containing materials using medium temperature pressure leaching
07/29/2004DE10302020A1 New beta-isoindigo compounds, useful as pigments or dyes in e.g. toners, lacquers, plastics or inks, are obtained by condensation of a bis-isoindolidene-diimine with an alicyclic or heterocyclic compound
07/29/2004DE10301519A1 New substituted 9-keto-spinosyn derivatives, useful for control of animal pests and microorganisms, in plant protection and veterinary medicine, also new intermediates
07/29/2004CA2513436A1 Hydroxamid acid derivatives as histone deacetylase (hdac) inhibitors
07/29/2004CA2513132A1 New carboxylic acids and the esters thereof, pharmaceutical compositions containing these compounds and processes for the preparation thereof
07/29/2004CA2512813A1 Use of substituted 2-phenylbenzimidazoles as phamaceutical compositions
07/29/2004CA2512257A1 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands